Literature DB >> 6467148

The role of pharmacokinetics in (combination) chemotherapy.

J G McVie.   

Abstract

Measurements of the behavior of a drug in the body, so-called pharmacokinetics, can help to establish that a given dose of drug reaches its target, that a degree of metabolism, required or not required, takes place, and that clearance either by bile, breath, or urine is achieved. Whereas manipulation of these parameters is not usually of value in improving response rates, insight into pharmacokinetics may often explain failure of effect, may assist in prediction and/or prevention of toxicity, and should be exploited to provide guidelines for optimal dosage and scheduling. In combination chemotherapy, drug monitoring is also indicated to detect and eventually exploit drug interactions.

Entities:  

Mesh:

Year:  1984        PMID: 6467148     DOI: 10.1002/1097-0142(19840915)54:1+<1175::aid-cncr2820541314>3.0.co;2-3

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

1.  Computational analysis of drug transport in tumor microenvironment as a critical compartment for nanotherapeutic pharmacokinetics.

Authors:  Arturas Ziemys; Steve Klemm; Miljan Milosevic; Kenji Yokoi; Mauro Ferrari; Milos Kojic
Journal:  Drug Deliv       Date:  2015-04-02       Impact factor: 6.419

2.  Liposomal doxorubicin extravasation controlled by phenotype-specific transport properties of tumor microenvironment and vascular barrier.

Authors:  Kenji Yokoi; Diana Chan; Milos Kojic; Miljan Milosevic; David Engler; Rise Matsunami; Tomonori Tanei; Yuki Saito; Mauro Ferrari; Arturas Ziemys
Journal:  J Control Release       Date:  2015-09-25       Impact factor: 9.776

3.  Clinical research in oncology: in memory of Professor Gordon McVie.

Authors:  Ian F Tannock
Journal:  Ecancermedicalscience       Date:  2022-01-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.